KLOW (BPC-157 + TB-500 + GHK-Cu + KPV)

Lincoln Park, Chicago

What Is KLOW Peptide Therapy?

KLOW is a combination peptide protocol that includes four peptides: BPC-157 (Body Protection Compound-157), TB-500 (a fragment of Thymosin Beta-4), GHK-Cu (a copper-binding tripeptide), and KPV (an anti-inflammatory tripeptide derived from alpha-MSH). Each peptide has a distinct mechanism of action. BPC-157 promotes local tissue repair and angiogenesis. TB-500 supports systemic cell migration and wound healing. GHK-Cu stimulates collagen and elastin production. KPV suppresses inflammatory pathways at the cellular level, particularly in the gut. The protocol is typically administered as subcutaneous injections over a 4-week or 8-week cycle.

If you have looked into our Repair & Glow protocol (BPC-157 + TB-500 + GHK-Cu), KLOW is the expanded version. The addition of KPV brings targeted anti-inflammatory and gut-healing support that the three-peptide blend does not cover on its own.

What Each Peptide Does (and What the Research Shows)

One thing we believe strongly: you deserve to know what is in your protocol and what the science actually says. Peptide therapy is promising, but it is also a space full of overclaiming. Here is an honest breakdown of each peptide in KLOW.

BPC-157 (Body Protection Compound-157)

BPC-157 is a synthetic 15-amino-acid peptide derived from a protective protein found naturally in human gastric juice. It works primarily by increasing VEGF expression (which promotes new blood vessel growth at injury sites) and activating cell adhesion pathways that speed tissue repair.

Preclinical research (animal studies) is extensive, with over 35 published studies showing benefits for tendon, ligament, muscle, and gut healing. Human data is still limited. A 2024 pilot study of 12 patients with chronic knee pain found that 7 of 12 reported relief lasting six or more months after a single BPC-157 injection. A 2025 safety study confirmed IV BPC-157 was well tolerated in healthy adults with no adverse events. More human trials are needed, but the early signals and the depth of preclinical evidence are why BPC-157 remains the most widely used recovery peptide in clinical practice.

TB-500 (Thymosin Beta-4 Fragment)

TB-500 is a 43-amino-acid synthetic fragment of Thymosin Beta-4, a protein present in nearly every human cell. While BPC-157 works locally at the injury site, TB-500 operates systemically. It regulates actin (the protein that forms your cells' structural scaffolding), promotes stem cell migration to damaged tissue, and stimulates new blood vessel formation.

Thymosin Beta-4 has been studied in Phase II clinical trials for corneal wound healing, where it showed a 59% reduction in corneal staining compared to placebo. Cardiac research has shown it may help reduce scar tissue after heart injury. TB-500 specifically has limited published human data, though practitioner reports over the past decade consistently describe accelerated recovery from soft tissue injuries. Like BPC-157, it is not FDA-approved, and we are transparent about that distinction.

GHK-Cu (Copper Peptide)

GHK-Cu is a naturally occurring tripeptide that binds copper and delivers it into cells. First identified in 1973, it is the most clinically studied peptide in this protocol. Plasma levels of GHK-Cu decline roughly 60% between age 20 and age 60, which tracks closely with the body's decreasing ability to heal and regenerate tissue.

Randomized, double-blind human trials have shown that GHK-Cu application produces a 55.8% reduction in wrinkle volume and a 32.8% reduction in wrinkle depth compared to controls over 8 weeks. Beyond skin, GHK-Cu affects the expression of over 4,000 genes, upregulating restorative processes and suppressing inflammatory ones. It stimulates collagen, elastin, and glycosaminoglycan synthesis, which is why it plays a key structural role in KLOW: while BPC-157 and TB-500 handle the acute repair work, GHK-Cu rebuilds the foundation.

KPV (Anti-Inflammatory Tripeptide)

KPV is a three-amino-acid peptide (Lysine-Proline-Valine) derived from alpha-melanocyte-stimulating hormone. Its primary mechanism is suppressing NF-kB activation, a master switch that controls inflammatory gene expression throughout the body. In the gut specifically, KPV is absorbed through a dedicated intestinal transporter (PepT1), allowing it to calm inflammation directly inside epithelial cells.

Animal studies of colitis have shown KPV significantly reduces gut inflammation, body weight loss, and pro-inflammatory cytokine activity. It also demonstrates antimicrobial properties against common pathogens. Human clinical data for KPV specifically is limited, but the anti-inflammatory pathway it targets (NF-kB) is one of the most studied mechanisms in medicine. KPV is the peptide that makes KLOW more than a recovery protocol. It is the difference between repairing tissue in an inflamed environment versus repairing tissue in a calm one.

Who Is Peptide Therapy For (and Who Should Wait)?

KLOW is designed for adults dealing with one or more of the following:

• Nagging injuries or slow-healing soft tissue damage (tendons, ligaments, muscles)
• Post-surgical recovery support
• Chronic inflammation or joint stiffness
• Gut issues (bloating, food sensitivities, intestinal permeability)
• Skin quality decline, thinning skin, or slow wound healing
• General "wearing down" feeling, especially in patients over 35 whose natural peptide levels have declined

Many of our peptide therapy patients in Chicago are active adults, runners, CrossFitters, weekend athletes, and professionals who need to recover faster and feel better without extended downtime.

This is not right for everyone. KLOW is not appropriate for patients who are pregnant or breastfeeding, have active cancer or a recent cancer history, or are on immunosuppressive therapy. If you have a bleeding disorder or are taking blood thinners, your provider will assess whether peptide therapy is safe for you. Your provider reviews every patient's history before prescribing.

Why 503A Pharmacy Sourcing Matters

Not all peptides are created equal. The quality gap between pharmaceutical-grade and "research-grade" peptides is significant, and it matters for both safety and results.

503A Compounding Pharmacy (What Better Med Spa Uses)

Prepared by FDA-registered, state-board-regulated pharmacies. Must comply with USP standards for sterility, potency, and purity. Requires a physician prescription. Every batch is prepared under controlled conditions with pharmaceutical-grade ingredients. This is the standard of care for clinical peptide therapy.

Research-Grade Peptides (What You Find Online)

Labeled "for research use only" and cannot legally be sold for human use. No guaranteed purity, sterility, or accurate dosing. Often sourced from unregulated overseas labs. No physician oversight. Many of the adverse events attributed to peptides trace back to contaminated or mislabeled research-grade products, not the peptides themselves.

At Better Med Spa, every KLOW protocol is sourced from a licensed 503A compounding pharmacy. We never use research-grade peptides. Period.

Curious whether KLOW peptide therapy is right for you?

Book a consultation at our Lincoln Park clinic or via telehealth (available across Illinois). Dr. Brechner will review your health history, discuss your goals, and determine whether peptide therapy makes sense for your situation. No pressure, no obligation.

Book a Consultation

Or call (312) 285-2618

How the KLOW Protocol Works at Better Med Spa

Here is what the process looks like from start to finish.

Step 1: Consultation. You meet with a provider (in person at our Lincoln Park clinic or via telehealth if you are elsewhere in Illinois). They review your medical history, current medications, and goals. If KLOW is a good fit, he writes the prescription. If it is not, he will tell you directly and suggest alternatives.

Step 2: Pharmacy fulfillment. Your KLOW protocol is prepared by our 503A compounding pharmacy partner and shipped to the clinic or directly to your door.

Step 3: Treatment. KLOW is administered as subcutaneous injections. Your provider walks you through proper injection technique at your first visit. Most patients self-administer at home after that initial instruction. The protocol is available in two options:

• Standard protocol (4 or 8 weeks): For general recovery, inflammation management, gut support, and wellness optimization.
• Injury protocol (4 or 8 weeks): Higher dosing for active injuries, post-surgical recovery, or acute musculoskeletal issues.

Step 4: Cycling. We recommend 8 weeks on, followed by 4 weeks off. This cycling approach allows your body to consolidate the healing response. Many patients do 2-3 cycles per year depending on their goals and how they respond.

What to expect along the way: Most patients report reduced gut symptoms and lower general inflammation within the first week. Pain and mobility improvements from BPC-157 often become noticeable between days 5 and 14. Tissue-level healing accelerates through weeks 2-4. Skin texture improvements from GHK-Cu typically emerge around weeks 4-6, with full collagen remodeling continuing through week 12. Downtime is minimal. You may notice mild redness at the injection site for a day or two, and some patients experience slight fatigue or nausea during the first few days as the peptides begin working. Normal activity, including exercise, can continue throughout the protocol.

KLOW Peptide Therapy Pricing in Chicago

We publish our pricing because you should know what a treatment costs before you book. Here is what KLOW costs at Better Med Spa.

Standard Protocol

$400 for 1 month (4 weeks) or $690 for 2 months (8 weeks). Recommended for general recovery, gut support, inflammation management, and wellness optimization. The 2-month option saves $110 compared to buying two single months.

Injury Protocol

$600 for 1 month (4 weeks) or $1,040 for 2 months (8 weeks). Higher dosing for active injuries, post-surgical support, or acute musculoskeletal repair. The 2-month option saves $160 compared to two single months.

Both options include your medical evaluation, the compounded KLOW blend, injection supplies, and ongoing provider access for questions during your cycle. Better Med Spa members receive additional savings on peptide protocols.

For context, purchasing BPC-157, TB-500, GHK-Cu, and KPV individually through separate prescriptions would typically cost significantly more per month, plus you would need to manage four separate products, dosing schedules, and injection protocols. KLOW consolidates everything into one blend at one price.

Combining KLOW with Other Better Med Spa Treatments

Peptide therapy works well on its own, but it also pairs naturally with several other treatments we offer at our Chicago clinic.

KLOW + GLP-1 microdose therapy. For patients working on body composition, KLOW's anti-inflammatory and tissue-repair benefits complement the appetite regulation and metabolic support of low-dose semaglutide or tirzepatide. The two protocols address different systems and can run concurrently.

KLOW + PRP hair restoration. GHK-Cu is one of the most studied peptides for hair growth stimulation. Patients already using PRP for hair thinning may see compounding benefits from a KLOW cycle, since GHK-Cu supports the same follicular regeneration pathways from the inside.

KLOW + RF microneedling. If your goals include skin quality, the collagen stimulation from GHK-Cu pairs with the surface-level remodeling from RF microneedling. One works beneath the skin, the other works at the surface.

‍

Ready to find out if KLOW peptide therapy is right for you?

Book a consultation with Dr. Brechner at our Lincoln Park, Chicago clinic or via telehealth anywhere in Illinois. We will review your goals, your health history, and whether KLOW is the right protocol for your situation.

‍

Book Your Consultation

Dr. Brett Brechner, DO  |  Medical Director, Better Med Spa & Wellness

Dr. Brechner oversees all medical protocols at Better Med Spa in Lincoln Park, Chicago, including peptide therapy, weight management, and regenerative treatments.

‍